Image

Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine Market – Industry Trends and Forecast to 2030

Pharmaceutical

Image

Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Published Report
  • Jun 2023
  • Country Level
  • 350 Pages
  • No of Tables: 270
  • No of Figures: 329

Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine Market, By Product (Vaccines, Medication, and Supplements), Animal Type (Food Production and Companion Animals), Dosage (Solid, Liquid, and Semi-Solid), Route of Administration (Oral, Parenteral, and Topical), Application (Foot and Mouth Disease, Autoimmune Diseases, Bacterial Diseases, Helminthes Infection, Bluetongue, Canine Atopic Dermatitis, and Others), End User (Hospitals, Veterinary Clinics, Homecare Settings, and Laboratories), Distribution Channel (Direct Tender, Retail Sales, Online Pharmacy, and Others) - Industry Trends and Forecast to 2030.

Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine Market Analysis and Size

Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India veterinary medicine market is fragmented in nature, as it consists of many global players such as Zoetis Services LLC, Boehringer Ingelheim International GmbH., Virbac, Ceva, and Dechra Pharmaceuticals PLC. among others. The presence of these companies produces competitive prices for veterinary medicines across the region. Due to the presence of these players at regional and international levels, suppliers and manufacturers offer products with different specifications and characteristics in all budgets. The rising pet ownership and humanization of pets are driving the market growth. Additionally, the rising prevalence of animal diseases is expected to drive the market growth.

Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine MarketIndonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine Market

Data Bridge Market Research analyzes that, Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India veterinary medicine market is expected to reach a value of USD 6,811.52 million by 2030, at a CAGR of 10.1% during the forecast period. This market report also covers pricing analysis and technological advancements in depth.

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in Million, Volumes in Units, Pricing in USD

Segments Covered

Product (Vaccines, Medication, and Supplements), Animal Type (Food Production and Companion Animals), Dosage (Solid, Liquid, and Semi-Solid), Route of Administration (Oral, Parenteral, and Topical), Application (Foot and Mouth Disease, Autoimmune Diseases, Bacterial Diseases, Helminthes Infection, Bluetongue, Canine Atopic Dermatitis, and Others), End User (Hospitals, Veterinary Clinics, Homecare Settings, and Laboratories), Distribution Channel (Direct Tender, Retail Sales, Online Pharmacy, and Others)

Countries Covered

India, Australia, China, Indonesia, Malaysia, New Zealand, Korea, Vietnam, Thailand, and Philippines

Market Players Covered

Zoetis Services LLC (U.S.), Boehringer Ingelheim International GmbH.(Germany), Virbac (France), Ceva (France), Dechra Pharmaceuticals PLC (England), HUVEPHARMA (Bulgaria), Phibro Animal Health Corporation (U.S.), Kemin Industries, Inc.(U.S.), Vetoquinol (France), Mankind Pharma (India), Indian Immunologicals Ltd.(India), ECO Animal Health Ltd (U.K.), Biologische Heilmittel Heel GmbH, Alivira Animal Health Limited, Jurox Pty Limited, Biogénesis Bagó (Germany), Bentoli (U.S.), Inovet (Hungary), MSD Animal Health (U.S.), Zovix Pharmaceuticals (India), and Valor Chemical Co., Ltd (China) among others

Market Definition

The veterinary medicines market refers to the industry that develops, produces, and sells medicines and other healthcare products for animals. This includes medicines for pets, livestock, and other animals. The market is driven by the increasing demand for animal healthcare services and products, and the growing awareness of the importance of animal health and welfare. The veterinary medicines market includes various products such as vaccines, antibiotics, parasiticides, and anti-inflammatory drugs. The market is also influenced by factors such as government regulations, advancements in technology, and the level of competition.

Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:

DRIVERS

Increasing Pet Ownership and Humanization of Pets

The experience of pet ownership exists across many cultures in the world. In many countries, such as India, China, Korea, Thailand, Vietnam, and Australia a majority of people live with pets. Pet ownership is increasing due to a combination of factors such as the desire for companionship, health benefits, changing attitudes towards pets, and increased disposable income. Pets provide companionship and emotional support, which is especially important for people who live alone or have limited social interactions. Studies have shown that pet ownership can have numerous health benefits, including lower blood pressure, reduced stress levels, and improved mental health. Thus, more people move to urban areas, they may feel isolated and disconnected from nature. Owning a pet can provide a sense of connection to the natural world and a source of comfort.

Again as disposable income increases, people may have more money to spend on pets and pet-related expenses such as food, toys, and healthcare. Attitudes towards pets have changed over time, with many people now viewing pets as members of the family rather than just animals. The rise of social media has also contributed to the popularity of pet ownership, with many people sharing photos and stories of their pets online and connecting with other pet owners. Similarly, the humanization of pets refers to the trend of treating pets as members of the family and providing them with the same level of care and attention as human family members. This includes providing high-quality food, healthcare, and grooming services, and treating pets as companions and sources of emotional support.

Thus, more people adopt pets, the overall demand for veterinary medicines increases to meet the needs of these pets. Pet owners are increasingly interested in preventive healthcare for their pets, which involves regular check-ups and vaccinations. This leads to an increased demand for veterinary medicines such as vaccines and flea and tick preventives. Overall, pet adoption leads to an increased demand for veterinary medicines as pet owners seek to provide their pets with the best possible care and treatment. This trend is expected to continue as pet ownership continues to grow and pet owners become more invested in their pets' health and well-being.

Growing Prevalence of Animal Diseases

Growing animal diseases are related to increasing veterinary medicines because as the number of animal diseases increases, the demand for effective treatments and preventative measures also increases. This leads to the development and production of more veterinary medicines to address the various diseases and conditions affecting animals.

The use of veterinary medicines is essential in managing and controlling animal diseases, and their effectiveness can help reduce the spread of diseases and improve animal health. Therefore, the increasing need for veterinary medicines is directly related to the growing number of animal diseases and the need for effective interventions to manage them.

For instance,

  • In December 2022, as per NCBI, Malaysia experienced an outbreak of Highly Pathogenic Avian Influenza (HPAI) 2021, which is a viral disease affecting birds. The outbreak resulted in the culling of thousands of birds, leading to a significant loss in the country's poultry industry
  • In September 2021, an article published in Springer Nature that in 2019, China experienced an outbreak of African Swine Fever (ASF), which is a highly contagious disease affecting pigs. The outbreak resulted in the culling of millions of pigs, leading to a significant loss in the country's pork industry

According to above instances, it can be concluded that the growing prevalence of animal diseases is driving the growth of Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India veterinary medicine market in the forecast period.

Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine Market

OPPORTUNITY

 Development of Novel and Personalized Veterinary Medicines

The development of novel and personalized veterinary medicines presents a significant opportunity for the veterinary medicines market. Personalized veterinary medicine refers to the use of targeted therapies based on a specific animal's genetic makeup, medical history, and other factors. This approach allows for more precise and effective treatment, with fewer side effects. The development of personalized veterinary medicines is closely related to advances in genomics and other areas of biomedical research. These advances have enabled researchers to better understand the underlying causes of diseases in animals and to develop targeted therapies that address these causes. Furthermore, there is a growing demand for personalized veterinary medicines among pet owners and veterinarians.

This demand is driving innovation in the veterinary medicines market, with new products and therapies being developed to address a wide range of conditions. In addition, the development of personalized veterinary medicines is also driving growth in the animal diagnostics market. As more animals are diagnosed with specific diseases or conditions, there is an increasing need for diagnostic tests that can accurately identify these conditions. Overall, the development of novel and personalized veterinary medicines is creating significant opportunities for growth in the veterinary medicines market. As research and development continue to advance, we can expect to see continued innovation and growth in this important sector.

RESTRAINT / CHALLENGE

High Cost of Veterinary Medicines

High prices of veterinary medicines may limit the affordability of pet owners and farmers, leading to reduced demand for these medicines. This could result in lower revenues for veterinary medicine manufacturers and distributors. When pet owners or farmers cannot afford the high cost of veterinary medicines, they may not comply with the recommended treatment regimen. This could result in poor health outcomes for animals and reduced effectiveness of the medicine.

High prices of veterinary medicines may attract new entrants to the market who offer lower-priced alternatives. This could increase competition and reduce market share for existing manufacturers. High prices of veterinary medicines may attract regulatory scrutiny and lead to increased regulation of the market. This could increase costs for manufacturers and distributors, leading to higher prices for consumers. Overall, the high cost of veterinary medicines can limit the growth of the market by reducing demand, increasing competition, and attracting regulatory attention.

Post-COVID-19 Impact on the Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine Market

COVID-19 created a negative impact on the Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India veterinary medicine market. The lockdown restriction led to the emergence of various challenges such as decreased transportation and communication facilities as well as decreased veterinary hospital visits, thereby delaying the treatment procedures.

The COVID-19 pandemic has impacted the market to an extent in negative manner. However, increasing government support and advancements in veterinary medicines and technology is expected to provide lucrative opportunities for market growth. Moreover, increasing partnerships, acquisitions, and collaboration among market players are expected to further fuel the market growth. Also, the growth was high since the market opened after COVID-19, and it is expected that there would be considerable growth in the sector. The market players are conducting multiple activities to improve veterinary medicines. With this, the companies will bring advancement and innovation to the market.

Recent Developments

  • In April 2023, MSD Animal Health received marketing authorization from European Commission for BOVILIS Nasalgen-C live vaccine for cattle. This has helped the company to establish its global presence in the market.
  • In September 2022, Zoetis Services LLC announced that it has completed the acquisition of Jurox, a privately held animal health company that develops, manufactures, and markets a wide range of veterinary medicines for treating livestock and companion animals.

Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine Market Scope

Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India veterinary medicine market is segmented into seven notable segments based on product, animal type, dosage, route of administration, application, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

  • Vaccines
  • Medication
  • Supplements

Based on product, the market is segmented into vaccines, medication, and supplements.

Animal Type

  • Food Production
  • Companion Animals

Based on animal type, the market is segmented into food production and companion animals.

Dosage

  • Solid
  • Liquid
  • Semi-Solid

Based on dosage, the market is segmented into solid, liquid, and semi-solid.

Route of Administration

  • Oral
  • Parenteral
  • Topical

Based on route of administration, the market is segmented into oral, parenteral, and topical.

Application

  • Foot and Mouth Disease
  • Autoimmune Diseases
  • Bacterial Diseases
  • Helminthes Infection
  • Bluetongue
  • Canine Atopic Dermatitis
  • Others

Based on application, the market is segmented into foot and mouth disease, autoimmune diseases, bacterial diseases, helminthes infection, bluetongue, canine atopic dermatitis, and others.

End User

  • Hospitals
  • Veterinary Clinics
  • Homecare Settings
  • Laboratories

Based on end user, the market is segmented into hospitals, veterinary clinics, homecare settings, and laboratories.

Distribution Channel

  • Direct Tender
  • Retail Sales
  • Online Pharmacy
  • Others

Based on distribution channel, the market is segmented into direct tender, retail sales, online pharmacy, and others.

Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine Market

Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine Market Analysis/Insights

The Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India veterinary medicine market is analyzed and market size insights and trends are provided by country, product, animal type, dosage, route of administration, application, end user and distribution channel as referenced above. The countries covered in this market report are India, Australia, China, Indonesia, Malaysia, New Zealand, Korea, Vietnam, Thailand, and Philippines. India is dominating the market with the largest market share. This share is attributable to the presence of key market players such as Zoetis Services LLC, Boehringer Ingelheim International GmbH., Virbac, Ceva, and Dechra Pharmaceuticals PLC. among others. Rising pet ownership and humanization of pets are anticipated to fuel the market growth during the forecast period in this region.

The country section of the report also provides individual market-impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like downstream and upstream value chain analysis, technical trends, Porter’s five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine Market Share Analysis

The Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India veterinary medicine market competitive landscape provides details of the competitor. Details included are company overview, company financials, revenue generated, market potential, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the market.

Some of the major market players operating in the Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India veterinary medicine market are Zoetis Services LLC (U.S.), Boehringer Ingelheim International GmbH.(Germany), Virbac (France), Ceva (France), Dechra Pharmaceuticals PLC (England), HUVEPHARMA (Bulgaria), Phibro Animal Health Corporation (U.S.), Kemin Industries, Inc.(U.S.), Vetoquinol (France), Mankind Pharma (India), Indian Immunologicals Ltd.(India), ECO Animal Health Ltd (U.K.), Biologische Heilmittel Heel GmbH, Alivira Animal Health Limited, Jurox Pty Limited, Biogénesis Bagó (Germany), Bentoli (U.S.), Inovet (Hungary), MSD Animal Health (U.S.), Zovix Pharmaceuticals (India), and Valor Chemical Co., Ltd (China) among others.


SKU-

TABLE 1 INDIA VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 2 AUSTRALIA VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 3 CHINA VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 4 INDONESIA VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 5 MALAYSIA VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 6 NEW ZEALAND VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 7 KOREA VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 8 VIETNAM VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 9 THAILAND VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 10 PHILIPPINES VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 11 INDIA VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 12 AUSTRALIA VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 13 CHINA VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 14 INDONESIA VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 15 MALAYSIA VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 16 NEW ZEALAND VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 17 KOREA VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 18 VIETNAM VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 19 THAILAND VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 20 PHILIPPINES VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 21 INDIA MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 22 AUSTRALIA MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 23 CHINA MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 24 INDONESIA MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 25 MALAYSIA MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 26 NEW ZEALAND MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 27 KOREA MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 28 VIETNAM MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 29 THAILAND MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 30 PHILIPPINES MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 31 INDIA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 32 AUSTRALIA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 33 CHINA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 34 INDONESIA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 35 MALAYSIA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 36 NEW ZEALAND ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 37 KOREA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 38 VIETNAM ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 39 THAILAND ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 40 PHILIPPINES ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 41 INDIA ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 42 AUSTRALIA ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 43 CHINA ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 44 INDONESIA ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 45 MALAYSIA ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 46 NEW ZEALAND ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 47 KOREA ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 48 VIETNAM ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 49 THAILAND ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 50 PHILIPPINES ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 51 INDIA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 52 AUSTRALIA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 53 CHINA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 54 INDONESIA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 55 MALAYSIA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 56 NEW ZEALAND ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 57 KOREA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 58 VIETNAM ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 59 THAILAND ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 60 PHILIPPINES ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 61 INDIA OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 62 AUSTRALIA OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 63 CHINA OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 64 INDONESIA OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 65 MALAYSIA OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 66 NEW ZEALAND OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 67 KOREA OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 68 VIETNAM OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 69 THAILAND OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 70 PHILIPPINES OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 71 INDIA MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 72 AUSTRALIA MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 73 CHINA MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 74 INDONESIA MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 75 MALAYSIA MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 76 NEW ZEALAND MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 77 KOREA MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 78 VIETNAM MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 79 THAILAND MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 80 PHILIPPINES MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 81 INDIA KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 82 AUSTRALIA KAPPA AGONIST-MU ANTAGONIST S IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 83 CHINA KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 84 INDONESIA KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 85 MALAYSIA KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 86 NEW ZEALAND KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 87 KOREA KAPPA AGONIST-MU ANTAGONIST S IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 88 VIETNAM KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 89 THAILAND KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 90 PHILIPPINES KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 91 INDIA PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 92 AUSTRALIA PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 93 CHINA PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 94 INDONESIA PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 95 MALAYSIA PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 96 NEW ZEALAND PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 97 KOREA PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 98 VIETNAM PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 99 THAILAND PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 100 PHILIPPINES PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 101 INDIA PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 102 AUSTRALIA PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 103 CHINA PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 104 INDONESIA PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 105 MALAYSIA PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 106 NEW ZEALAND PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 107 KOREA PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 108 VIETNAM PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 109 THAILAND PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 110 PHILIPPINES PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 111 INDIA ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 112 AUSTRALIA ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 113 CHINA ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 114 INDONESIA ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 115 MALAYSIA ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 116 NEW ZEALAND ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 117 KOREA ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 118 VIETNAM ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 119 THAILAND ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 120 PHILIPPINES ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 121 INDIA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 122 AUSTRALIA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 123 CHINA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 124 INDONESIA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 125 MALAYSIA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 126 NEW ZEALAND ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 127 KOREA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 128 VIETNAM ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 129 THAILAND ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 130 PHILIPPINES ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 131 INDIA ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 132 AUSTRALIA ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 133 CHINA ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 134 INDONESIA ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 135 MALAYSIA ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 136 NEW ZEALAND ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 137 KOREA ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 138 VIETNAM ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 139 THAILAND ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 140 PHILIPPINES ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 141 INDIA HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 142 AUSTRALIA HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 143 CHINA HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 144 INDONESIA HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 145 MALAYSIA HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 146 NEW ZEALAND HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 147 KOREA HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 148 VIETNAM HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 149 THAILAND HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 150 PHILIPPINES HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 151 INDIA SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 152 AUSTRALIA SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 153 CHINA SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 154 INDONESIA SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 155 MALAYSIA SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 156 NEW ZEALAND SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 157 KOREA SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 158 VIETNAM SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 159 THAILAND SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 160 PHILIPPINES SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 161 INDIA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 162 AUSTRALIA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 163 CHINA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 164 INDONESIA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 165 MALAYSIA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 166 NEW ZEALAND VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 167 KOREA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 168 VIETNAM VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 169 THAILAND VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 170 PHILIPPINES VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 171 INDIA FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 172 AUSTRALIA FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 173 CHINA FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 174 INDONESIA FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 175 MALAYSIA FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 176 NEW ZEALAND FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 177 KOREA FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 178 VIETNAM FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 179 THAILAND FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 180 PHILIPPINES FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 181 INDIA COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 182 AUSTRALIA COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 183 CHINA COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 184 INDONESIA COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 185 MALAYSIA COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 186 NEW ZEALAND COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 187 KOREA COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 188 VIETNAM COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 189 THAILAND  COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 190 PHILIPPINES COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 191 INDIA VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 192 AUSTRALIA VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 193 CHINA VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 194 INDONESIA VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 195 MALAYSIA VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 196 NEW ZEALAND VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 197 KOREA VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 198 VIETNAM VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 199 THAILAND VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 200 PHILIPPINES VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 201 INDIA SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 202 AUSTRALIA SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 203 CHINA SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 204 INDONESIA SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 205 MALAYSIA SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 206 NEW ZEALAND SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 207 KOREA SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 208 VIETNAM SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 209 THAILAND SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 210 PHILIPPINES SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 211 INDIA LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 212 AUSTRALIA LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 213 CHINA LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 214 INDONESIA LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 215 MALAYSIA LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 216 NEW ZEALAND LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 217 KOREA LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 218 VIETNAM LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 219 THAILAND LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 220 PHILIPPINES LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 221 INDIA SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 222 AUSTRALIA SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 223 CHINA SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 224 INDONESIA SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 225 MALAYSIA SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 226 NEW ZEALAND SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 227 KOREA SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 228 VIETNAM SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 229 THAILAND SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 230 PHILIPPINES SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 231 INDIA VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 232 AUSTRALIA VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 233 CHINA VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 234 INDONESIA VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 235 MALAYSIA VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 236 NEW ZEALAND VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 237 KOREA VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 238 VIETNAM VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 239 THAILAND VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 240 PHILIPPINES VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 241 INDIA VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 242 AUSTRALIA VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 243 CHINA VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 244 INDONESIA VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 245 MALAYSIA VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 246 NEW ZEALAND VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 247 KOREA VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 248 VIETNAM VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 249 THAILAND VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 250 PHILIPPINES VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 251 INDIA VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 252 AUSTRALIA VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 253 CHINA VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 254 INDONESIA VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 255 MALAYSIA VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 256 NEW ZEALAND VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 257 KOREA VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 258 VIETNAM VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 259 THAILAND VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 260 PHILIPPINES VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 261 INDIA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 262 AUSTRALIA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 263 CHINA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 264 INDONESIA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 265 MALAYSIA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 266 NEW ZEALAND VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 267 KOREA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 268 VIETNAM VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 269 THAILAND VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 270 PHILIPPINES VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine Market size will be worth USD 6,811.52 million by 2030.
The Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine Market growth rate will be 10.1% by 2030.
Increasing Pet Ownership and Humanization of Pets and Growing Prevalence of Animal Diseases are the growth drivers of the Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine Market.
The product, animal type, dosage, route of administration, application, end user, and distribution channel are the factors on which the Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine Market research is based.
The major companies in the Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine Market are Zoetis Services LLC (U.S.), Boehringer Ingelheim International GmbH.(Germany), Virbac (France), Ceva (France), Dechra Pharmaceuticals PLC (England), HUVEPHARMA (Bulgaria), Phibro Animal Health Corporation (U.S.), Kemin Industries, Inc.(U.S.), Vetoquinol (France), Mankind Pharma (India), Indian Immunologicals Ltd.(India), ECO Animal Health Ltd (U.K.), Biologische Heilmittel Heel GmbH, Alivira Animal Health Limited, Jurox Pty Limited, Biogénesis Bagó (Germany), Bentoli (U.S.), Inovet (Hungary), MSD Animal Health (U.S.), Zovix Pharmaceuticals (India), and Valor Chemical Co., Ltd (China).
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials